-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Bulk drugs refer to the raw materials used in the production of various preparations.
They are the effective ingredients in the preparations.
They are various powders, crystals, extracts, etc.
, prepared by chemical synthesis, plant extraction, or biotechnology
.
In China, APIs have become a long-term advantage for the pharmaceutical industry to participate in international competition
.
While the total output is increasing year by year, the market operating income is also increasing
.
Especially since the outbreak of the epidemic, the global pharmaceutical industry chain has been impacted, which has further improved the strategic position of China's API industry
.
Strong export of raw materials (picture source: Pharmaceutical Network) It is worth mentioning that at present, many Chinese raw materials companies have also started to increase their export orders, and both export output and sales revenue have increased significantly
.
For example, recently, there were reports that Northeast Pharmaceutical's export orders for raw materials in November increased sharply, and both the sales volume and sales revenue of raw materials increased
.
Among them, the market for three types of APIs such as vitamins, amino acids, and antibiotics performed strongly, with sales volume and sales revenue increasing by more than 40% month-on-month
.
In addition, Proton also announced on November 30 that the company has received a new batch of "Purchase Orders" from a large US pharmaceutical company.
This order is a CDMO order related to a small molecule innovative drug from a customer.
The total order size is about For 217 million US dollars, more than 50% of the company's operating income last year
.
The strong export growth of APIs is actually due to the long-term growth momentum of the API industry
.
The industry believes that with the continuous growth of domestic enterprise API exports, API pharmaceutical equipment companies will also usher in more new opportunities
.
First of all, in different production links of APIs, a large number of production equipment with different missions are required
.
Such as equipment used for synthesis reaction, fermentation, extraction, crystallization, metering and material storage, such as reaction tanks, fermentation tanks, extraction equipment, etc.
; equipment used for solid-liquid separation, such as filtration equipment such as sterilization filters, filter presses, etc.
.
Therefore, in the context of the accelerated export of a large number of API companies and the upgrading and expansion of production, pharmaceutical equipment companies will also usher in more demand, and their market will naturally continue to expand accordingly.
.
It is understood that in order to respond to market competition and meet user needs, many domestic pharmaceutical equipment companies have already begun to take action
.
On November 19th, Chutian Technology released two innovative overall solutions for aseptic products, one of which is an overall solution for aseptic freeze-dried API isolators to deal with the problem of APIs
.
According to reports, the overall solution is developed for the aseptic freeze-dried API market, which can realize the continuity of freeze-drying, discharging, crushing, mixing and sub-packaging processes, and the entire process is isolated, sealed, and automated, which can help API users to meet the green Low-carbon requirements
.
At the same time, it can also help users reduce operation and maintenance costs, and reduce the impact of dust diffusion on the environment and personnel
.
In addition, in order to better export and meet the quality requirements of overseas customers for APIs, API companies' demand for green, environmentally friendly, and energy-efficient API equipment is actually growing rapidly
.
Therefore, many manufacturers of raw material medicine production equipment have been forced to accelerate the elimination of outdated technologies and begin to build more green, energy-saving and efficient equipment
.
In the face of this new opportunity, powerful API equipment manufacturers have taken the lead to create safer, greener, energy-saving, and efficient equipment
.
For example, through continuous research, some companies have developed a new combined multi-effect distilled water machine that can provide sterile pharmaceuticals, injections, large infusions, and biopharmaceuticals for the pharmaceutical industry
.
According to reports, this equipment can operate continuously for 240 days, saving 65% of energy in terms of water saving, industrial steam saving, and reduction of enterprise sewage pressure
.
Other companies have developed a biological deodorization equipment suitable for odor control in pharmaceutical and chemical industries.
Its biological purification process can effectively degrade related pollutants, such as hydrogen sulfide, ammonia, methane, and trimethylamine.
Processing
.
The analysis believes that in the future, while the export of China's API industry will continue to accelerate, it will continue to develop in the direction of global uniform standardization and standardization of high quality
.
Affected by this, in order to meet the increasing demand of domestic companies in the pharmaceutical raw materials, it will also continue to upgrade and develop towards high-end
.
In this context, more new opportunities will also usher in
.
They are the effective ingredients in the preparations.
They are various powders, crystals, extracts, etc.
, prepared by chemical synthesis, plant extraction, or biotechnology
.
In China, APIs have become a long-term advantage for the pharmaceutical industry to participate in international competition
.
While the total output is increasing year by year, the market operating income is also increasing
.
Especially since the outbreak of the epidemic, the global pharmaceutical industry chain has been impacted, which has further improved the strategic position of China's API industry
.
Strong export of raw materials (picture source: Pharmaceutical Network) It is worth mentioning that at present, many Chinese raw materials companies have also started to increase their export orders, and both export output and sales revenue have increased significantly
.
For example, recently, there were reports that Northeast Pharmaceutical's export orders for raw materials in November increased sharply, and both the sales volume and sales revenue of raw materials increased
.
Among them, the market for three types of APIs such as vitamins, amino acids, and antibiotics performed strongly, with sales volume and sales revenue increasing by more than 40% month-on-month
.
In addition, Proton also announced on November 30 that the company has received a new batch of "Purchase Orders" from a large US pharmaceutical company.
This order is a CDMO order related to a small molecule innovative drug from a customer.
The total order size is about For 217 million US dollars, more than 50% of the company's operating income last year
.
The strong export growth of APIs is actually due to the long-term growth momentum of the API industry
.
The industry believes that with the continuous growth of domestic enterprise API exports, API pharmaceutical equipment companies will also usher in more new opportunities
.
First of all, in different production links of APIs, a large number of production equipment with different missions are required
.
Such as equipment used for synthesis reaction, fermentation, extraction, crystallization, metering and material storage, such as reaction tanks, fermentation tanks, extraction equipment, etc.
; equipment used for solid-liquid separation, such as filtration equipment such as sterilization filters, filter presses, etc.
.
Therefore, in the context of the accelerated export of a large number of API companies and the upgrading and expansion of production, pharmaceutical equipment companies will also usher in more demand, and their market will naturally continue to expand accordingly.
.
It is understood that in order to respond to market competition and meet user needs, many domestic pharmaceutical equipment companies have already begun to take action
.
On November 19th, Chutian Technology released two innovative overall solutions for aseptic products, one of which is an overall solution for aseptic freeze-dried API isolators to deal with the problem of APIs
.
According to reports, the overall solution is developed for the aseptic freeze-dried API market, which can realize the continuity of freeze-drying, discharging, crushing, mixing and sub-packaging processes, and the entire process is isolated, sealed, and automated, which can help API users to meet the green Low-carbon requirements
.
At the same time, it can also help users reduce operation and maintenance costs, and reduce the impact of dust diffusion on the environment and personnel
.
In addition, in order to better export and meet the quality requirements of overseas customers for APIs, API companies' demand for green, environmentally friendly, and energy-efficient API equipment is actually growing rapidly
.
Therefore, many manufacturers of raw material medicine production equipment have been forced to accelerate the elimination of outdated technologies and begin to build more green, energy-saving and efficient equipment
.
In the face of this new opportunity, powerful API equipment manufacturers have taken the lead to create safer, greener, energy-saving, and efficient equipment
.
For example, through continuous research, some companies have developed a new combined multi-effect distilled water machine that can provide sterile pharmaceuticals, injections, large infusions, and biopharmaceuticals for the pharmaceutical industry
.
According to reports, this equipment can operate continuously for 240 days, saving 65% of energy in terms of water saving, industrial steam saving, and reduction of enterprise sewage pressure
.
Other companies have developed a biological deodorization equipment suitable for odor control in pharmaceutical and chemical industries.
Its biological purification process can effectively degrade related pollutants, such as hydrogen sulfide, ammonia, methane, and trimethylamine.
Processing
.
The analysis believes that in the future, while the export of China's API industry will continue to accelerate, it will continue to develop in the direction of global uniform standardization and standardization of high quality
.
Affected by this, in order to meet the increasing demand of domestic companies in the pharmaceutical raw materials, it will also continue to upgrade and develop towards high-end
.
In this context, more new opportunities will also usher in
.